The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis

38Citations
Citations of this article
67Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Aims: Mid-range ejection fraction is a new entity of heart failure (HF) with undetermined prognosis till now. In our systematic review and meta-analysis, we assess the mortality and hospitalization rates in mid-range ejection fraction HF (HFmrEF) and compare them with those of reduced ejection fraction heart failure (HFrEF) and preserved ejection fraction HF (HFpEF). Methods and results: We conducted our search in March 2018 in the following databases for relevant articles: PubMed, CENTRAL, Google Scholar, Web of Science, Scopus, NYAM, SIEGLE, GHL, VHL, and POPLINE. Our primary endpoint was assessing all-cause mortality and all-cause hospital re-admission rates in HFmrEF in comparison with HFrEF and HFpEF. Secondary endpoints were the possible causes of death and hospital re-admission. Twenty-five articles were included in our meta-analysis with a total of 606 762 adult cardiac patients. Our meta-analysis showed that HFmrEF had a lower rate of all-cause death than had HFrEF [relative risk (RR), 0.9; 95% confidence interval (CI), 0.85–0.94]. HFpEF showed a higher rate of cardiac mortality than did HFmrEF (RR, 1.09; 95% CI, 1.02–1.16). Also, HFrEF had a higher rate of non-cardiac mortality than had HFmrEF (RR, 1.31; 95% CI, 1.22–1.41). Conclusions: We detected a significant difference between HFrEF and HFmrEF regarding all-cause death, and non-cardiac death, while HFpEF differed significantly from HFmrEF regarding cardiac death.

References Powered by Scopus

Quantifying heterogeneity in a meta-analysis

26941Citations
N/AReaders
Get full text

Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement

22477Citations
N/AReaders
Get full text

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC

5552Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure: One-Year Outcomes From the CardioMEMS Post-Approval Study

146Citations
N/AReaders
Get full text

Heart failure in type 2 diabetes: current perspectives on screening, diagnosis and management

62Citations
N/AReaders
Get full text

CMR tissue characterization in patients with HFmrEF

36Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Altaie, S., & Khalife, W. (2018, December 1). The prognosis of mid-range ejection fraction heart failure: a systematic review and meta-analysis. ESC Heart Failure. Wiley-Blackwell. https://doi.org/10.1002/ehf2.12353

Readers over time

‘18‘19‘20‘21‘22‘23‘24‘2506121824

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 19

54%

Researcher 10

29%

Professor / Associate Prof. 3

9%

Lecturer / Post doc 3

9%

Readers' Discipline

Tooltip

Medicine and Dentistry 29

81%

Biochemistry, Genetics and Molecular Bi... 3

8%

Engineering 2

6%

Pharmacology, Toxicology and Pharmaceut... 2

6%

Save time finding and organizing research with Mendeley

Sign up for free
0